Elanix Biotechnologies (DUSE:ELN) - Stock Price, News & Analysis

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

ELN Stock Overview

Elanix Biotechnologies AG, a tissue regeneration company, engages in the development and commercialization of products for acute wound care.

About the company

ELN fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Rewards

Risk Analysis

Latest financial reports are more than a year old

Shares are highly illiquid

Does not have a meaningful market cap (€428K)

Elanix Biotechnologies AG Competitors

Epigenomics

XTRA:ECX

€616.0k

bioXXmed

XTRA:T5O

€565.1k

co.don

XTRA:CNW

€6.5m

Deutsche Biotech Innovativ

DUSE:DBI

€1.0m

Price History & Performance

Summary of all time highs, changes and price drops for Elanix Biotechnologies
Historical stock prices
Current Share Price	€0.0005
52 Week High	€0.0005
52 Week Low	€0.0005
Beta	0
11 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
33 Year Change	n/a
5 Year Change	n/a
Change since IPO	0%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	ELN	DE Biotechs	DE Market
7D	n/a	-0.3%	2.8%
1Y	n/a	-15.5%	8.6%

Return vs Industry: Insufficient data to determine how ELN performed against the German Biotechs industry.

Return vs Market: Insufficient data to determine how ELN performed against the German Market.

Price Volatility

Is ELN's price volatile compared to industry and market?
ELN volatility
ELN Average Weekly Movement	n/a
Biotechs Industry Average Movement	6.2%
Market Average Movement	4.9%
10% most volatile stocks in DE Market	11.9%
10% least volatile stocks in DE Market	2.4%

Stable Share Price: ELN has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine ELN's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
n/a	n/a	Lee-Ann Laurent-Applegate	www.elanixbiotechnologies.ch

Elanix Biotechnologies AG, a tissue regeneration company, engages in the development and commercialization of products for acute wound care. The company is based in Frankfurt am Main, Germany.

Elanix Biotechnologies AG Fundamentals Summary

How do Elanix Biotechnologies's earnings and revenue compare to its market cap?
ELN fundamental statistics
Market cap	€428.29k
Earnings (TTM)	-€4.46m
Revenue (TTM)	€280.19k

0.0x

P/S Ratio

0.0x

P/E Ratio

Is ELN overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ELN income statement (TTM)
Revenue	€280.19k
Cost of Revenue	€348.59k
Gross Profit	-€68.39k
Other Expenses	€4.39m
Earnings	-€4.46m

Last Reported Earnings

Jun 30, 2018

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did ELN perform over the long term?

See historical performance and comparison